Finch Therapeutics Raises $36 Million Series B, Bringing Total to $77 Million Post author:Sam Post published:February 28, 2018 Post category:BioPharma Finch Therapeutics closed on an oversubscribed Series B financing worth $36 million. Source: BioSpace You Might Also Like TrovaGene's PLK1 Inhibitor PCM-075 Demonstrates Synergy With A HDAC Inhibitor In Non-Hodgkin Lymphoma Cell Lines August 20, 2017 SoCal's Peregrine Names a New CEO, to Change Name to Avid Bioservices December 26, 2017 Help Wanted: Amazon Seeks Health Privacy Expert for 'New Initiative' January 16, 2018
TrovaGene's PLK1 Inhibitor PCM-075 Demonstrates Synergy With A HDAC Inhibitor In Non-Hodgkin Lymphoma Cell Lines August 20, 2017